Coverage
-
December 12, 2019
A Delaware federal judge won't give Orexo AB another chance to prove that a Teva unit's generic version of the opioid addiction treatment drug Suboxone infringes a patent covering its own drug Zubsolv.
1 other articles on this case.
View all »